DevinTaylor__ Posted - 13 hours ago

$LLY $MRK $AZN nice move from TMO, are you going same ?

Braveheart_13 Posted - 15 hours ago

$ALT Holy fuck this has the compensation within 3 months for investment banking services, JUST LIKE THE ONE FOR $LLY i think the bidding war is starting?! $AZN $PFE $VKTX

Braveheart_13 Posted - 15 hours ago

$ALT Now $AZN too... $PFE $LLY Wonder if $MRK is next? Maybe this means nothing but with all the latest developments with our obesity program, we'd be remiss if we didn't consider a bidding process may be in the works

Stocksrunner Posted - 15 hours ago

Midweek market buzz! $CHWY is on fire with a double upgrade, while $LMND gets some love after its investor day. $AZN navigates China headwinds with a neutral upgrade, and $ZIM smashes earnings estimates. But beware—Goldman warns of a rough road for Vodafone Idea $VOD https://stocksrunner.com/posts/1401

DefenseMania Posted - 17 hours ago

$GILD get in RCUS before GILD acquires them $14.45 A STEAL !!!!!!’ $AZN $BMY $LLY $MRK

_KarenDelacruz_ Posted - 18 hours ago

$AZN $NVS LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

Chipwars Posted - 19 hours ago

$AZN UBS upgraded Astrazeneca to a hold while maintaining its 12-month price target of 11,300 pence.

Chipwars Posted - 19 hours ago

$AZN Astrazeneca. Another upgrade and no Bearish MM's left : https://www.bloomberg.com/news/articles/2024-11-20/astrazeneca-loses-lone-bear-as-ubs-upgrades-after-china-led-rout

knuckleheadinvestco Posted - 1 day ago

$AZN my calls have awaken.

ANTHONYMOMO Posted - 1 day ago

$AZN $NCNC $CDT $WBUY $SOAR

ANTHONYMOMO Posted - 1 day ago

$AZN $NCNC $CDT $WBUY $SOAR

ANTHONYMOMO Posted - 1 day ago

$CDT $0.10 boom like $NCNC $SOAR and $WBUY . $AZN $63 bought 9.5M shares here. Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

Davidendz Posted - 1 day ago

$BVAXF $AZN $LLY $MRNA $PFE

neueinvestor Posted - 2 days ago

$ASST keep an eye on $CDT a very legit bio that has no business being at the price it is - 10% stake by $AZN

JeffGendron Posted - 2 days ago

$AZN It’s a question of time ! Solid project, expérience and good management.

miggy99 Posted - 2 days ago

$AZN

TheLionofwallstreet Posted - 2 days ago

$AIM bullish af! Now $PFE will surely be in the bidding war with $MRK and $AZN Celebrex X Ampligen

LDT79 Posted - 2 days ago

$MREO the delay in #Alvelestat could be because management is positive on clinical trial for Bronchiolitis Obliterans Syndrome with completion DEC 1st, 2024 - Alvelestat is worth even more now. This + amended agreement with $AZN might explain many things

TroyTiger Posted - 2 days ago

$TGTX I had to buy a small amount more, anything under $30 is a good buy in. We will run again and rumors will be realized I believe. $BMY, $SNY , $PFE , $AZN must have interest.

DooScooby7 Posted - 2 days ago

$IONQ $NVDA $AZN Perfect stop loss raid and long bulls know why.

Chipwars Posted - 2 days ago

$AZN Drugmaker AstraZeneca said on Monday that its Tagrisso asset had received a recommendation for EU approval on the back of LAURA Phase III trial results, which revealed it had extended median progression-free survival to more than three years.

Chipwars Posted - 2 days ago

$AZN Yet another recommendation for Astrazeneca. https://www.sharecast.com/news/news-and-announcements/astrazenecas-tagrisso-recommended-for-eu-approval--18089624.html

Chipwars Posted - 2 days ago

$AZN Astrazeneca https://www.sharesmagazine.co.uk/news/shares/astrazeneca-ceo-buys-20000-shares-travis-perkins-ceo-snaps-up-249218-and-asos-director-buys-directors-deals

Bastard_Factory Posted - 2 days ago

$THAR ...GOING to EXPLODE at OPEN ... $AZN $ZONE $UAVS

DonCorleone77 Posted - 2 days ago

$AAPL $AZN $TSM $BABA $GFL Soros boosts stake in AstraZeneca, exits Apple position George Soros' Soros Fund Management disclosed in an SEC filing its holdings as of September 30, 2024. Soros' new buys during the third quarter included, by size of position, Global Payments (GPN), Salesforce (CRM), and Synchrony Financial (SYF). Soros exited a number of positions during the quarter, including Apple (AAPL), Agilent Technologies (A), Biomarin Pharmaceuticals (BMRN), PG&E (PCG), and TSMC (TSM). Soros increased its stake in a number of holdings, including AstraZeneca (AZN), AerCap (AER), Alibaba (BABA), GFL Environmental (GFL), and JD.com (JD). Soros reduced its stake in a number of holdings, including by size of previous position, Liberty Broadband (LBRDK), Alphabet (GOOGL), Axonics (AXNX), and EchoStar (SATS).

DonCorleone77 Posted - 2 days ago

$AZN AstraZeneca's Tagrisso recommended for approval in EU by CHMP for certain NSCLC AstraZeneca's Tagrisso has been recommended for approval in the European Union for the treatment of adult patients with locally advanced, unresectable non-small cell lung cancer, or NSCLC, whose tumors have epidermal growth factor receptor exon 19 deletions or exon 21 substitution mutations and whose disease has not progressed during or following platinum-based chemoradiation therapy, or CRT, the company announced.

DonCorleone77 Posted - 3 days ago

$AZN FDA Cellular, Tissue & Gene Therapies Advisory Committee holds virtual meeting The Committee discusses and makes recommendations for AstraZeneca (AZN) supplemental Biologics License Application (sBLA) 125586/546 for Andexxa (coagulation factor Xa (recombinant), inactivated -zhzo), for patients treated with rivaroxaban or apixaban in a virtual meeting to be held on November 21 at 10 am.

TalkMarkets Posted - 4 days ago

Not-So-Big Pharma $AZN $BMY $LLY $MRK $NVO https://talkmarkets.com/content/stocks--equities/not-so-big-pharma?post=469428

valueforme Posted - 4 days ago

$AZN Core revenue streams are in oncology and rare diseases. China noise will go away, RFK has little impact on the AZN therapeutic focus. Buying

Braveheart_13 Posted - 5 days ago

$ALT Not sure why folks keep talking about the ATM being used. There is zero need for an ATM at this juncture because we have a global Phase 3 obesity program to leverage for nondilutive partnership funding. Better yet, we have a highly differentiated asset that can command market share across leading cardiometabolic verticals (obesity, CV, MASH) and will garner takeover interest. Even if we did use the ATM, what purpose would those funds serve? None! We are funded through 2026 for MASH and obesity/CV will be partnered out, not to mention significant financing opportunities that will arrive next year after MASH data... if we aren't already acquired by then. This week was massive accumulation IMHO. Partnership or BO before Christmas is still on the table and if not, we have JPM in January and that's the biggest life sciences investor conference in the world where M&A kicks off the new year. $AZN $MRK $AMGN